Sonova Holding (OTCMKTS:SONVY) Short Interest Update

Sonova Holding (OTCMKTS:SONVY) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totaling 36,769 shares, an increase of 219.5% from the December 31st total of 11,510 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 45,081 shares, the days-to-cover ratio is presently 0.8 days. Based on an average daily trading volume, of 45,081 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.0% of the company’s shares are sold short.

Sonova Stock Performance

Shares of Sonova stock opened at $55.20 on Friday. Sonova has a 12 month low of $47.55 and a 12 month high of $71.50. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The business has a fifty day simple moving average of $52.22 and a two-hundred day simple moving average of $54.78.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on SONVY shares. Rothschild Redb upgraded Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. BNP Paribas Exane began coverage on shares of Sonova in a report on Monday, October 20th. They issued an “underperform” rating for the company. Royal Bank Of Canada raised shares of Sonova to a “moderate buy” rating in a research report on Tuesday, November 18th. Finally, Zacks Research cut shares of Sonova from a “hold” rating to a “strong sell” rating in a research report on Tuesday, December 9th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold”.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.